KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Invested Capital (2018 - 2025)

Historic Return on Invested Capital for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Q3 2025 value amounting to 0.13%.

  • Amneal Pharmaceuticals' Return on Invested Capital rose 400.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.14% for FY2024, which is 500.0% up from last year.
  • Amneal Pharmaceuticals' Return on Invested Capital amounted to 0.13% in Q3 2025, which was up 400.0% from 0.1% recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Return on Invested Capital registered a high of 0.3% during Q3 2021, and its lowest value of 0.09% during Q2 2022.
  • Over the past 5 years, Amneal Pharmaceuticals' median Return on Invested Capital value was 0.09% (recorded in 2024), while the average stood at 0.08%.
  • As far as peak fluctuations go, Amneal Pharmaceuticals' Return on Invested Capital soared by 5500bps in 2021, and later tumbled by -3500bps in 2022.
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' Return on Invested Capital stood at 0.06% in 2021, then crashed by -161bps to 0.03% in 2022, then skyrocketed by 377bps to 0.1% in 2023, then surged by 53bps to 0.15% in 2024, then fell by -9bps to 0.13% in 2025.
  • Its Return on Invested Capital was 0.13% in Q3 2025, compared to 0.1% in Q2 2025 and 0.09% in Q1 2025.